Paper9083
Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions.
Duarte-Karim M and 2 others. Biochem Biophys Res Commun, 1976. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions. Papers, record 9083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9083
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Mitochondria, Muscle | Major topic |
| Myocardium | Major topic |
| Phospholipids | Major topic |
| Animals | |
| Binding Sites | |
| Cardiolipins | |
| DNA | |
| Hydrogen-Ion Concentration | |
| Kinetics | |
| Models, Biological |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37175395 | Exercise and Doxorubicin Modify Markers of Iron Overload and Cardiolipin Deficiency in Cardiac Mitochondria. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175395 | PubMed |
| 34587760 | Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy. | Arterioscler Thromb Vasc Biol | 2021 | https://conductscience.org/library/papers/34587760 | PubMed |
| 19002786 | Intracellular distribution of anthracyclines in drug resistant cells. | Cytotechnology | 1998 | https://conductscience.org/library/papers/19002786 | PubMed |
| 12841626 | The influence of lipoic acid on adriamycin induced nephrotoxicity in rats. | Mol Cell Biochem | 2003 | https://conductscience.org/library/papers/12841626 | PubMed |
| 9929491 | Binding of adriamycin to liposomes as a probe for membrane lateral organization. | Biophys J | 1999 | https://conductscience.org/library/papers/9929491 | PubMed |
| 8970871 | Noninvasive monitoring of intraocular pharmacokinetics of daunorubicin using fluorophotometry. | Int Ophthalmol | 1995 | https://conductscience.org/library/papers/8970871 | PubMed |
| 7274305 | Differential adriamycin distribution to blood components. | Eur J Drug Metab Pharmacokinet | 1981 | https://conductscience.org/library/papers/7274305 | PubMed |
| 6940195 | Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6940195 | PubMed |
| 6378238 | Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6378238 | PubMed |
| 4006046 | Lysosomal alterations in heart and liver of mice treated with doxorubicin. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4006046 | PubMed |
| 3742710 | Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sites. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3742710 | PubMed |
| 3412115 | Membrane lipid alteration: effect on cellular uptake of mitoxantrone. | Lipids | 1988 | https://conductscience.org/library/papers/3412115 | PubMed |
| 3370735 | Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3370735 | PubMed |
| 2822273 | A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroids. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/2822273 | PubMed |
| 2432879 | Conformation and mode of organization of amphiphilic membrane components: a conformational analysis. | Biochem J | 1986 | https://conductscience.org/library/papers/2432879 | PubMed |
| 1937080 | Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. | Graefes Arch Clin Exp Ophthalmol | 1991 | https://conductscience.org/library/papers/1937080 | PubMed |
| 1366656 | Doxorubicin effects on contractile structures and molecules. | Cytotechnology | 1990 | https://conductscience.org/library/papers/1366656 | PubMed |
| 373905 | Cardiotoxic effects of antitumor agents. | Cancer Chemother Pharmacol | 1978 | https://conductscience.org/library/papers/373905 | PubMed |
| 348587 | Anthracyclines--modern tumour-inhibiting agents. | Folia Microbiol (Praha) | 1978 | https://conductscience.org/library/papers/348587 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9083
GET https://conductscience.org/api/papers/v1/9083/authors